Preclinical efficacy of prexasertib in acute lymphoblastic leukemia.

Jason Ostergaard, Leslie M Jonart, Maryam Ebadi, Stacia L Koppenhafer, David J Gordon, Peter M Gordon
Author Information
  1. Jason Ostergaard: Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Minnesota, Minneapolis, MN, USA.
  2. Leslie M Jonart: Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Minnesota, Minneapolis, MN, USA.
  3. Maryam Ebadi: Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Minnesota, Minneapolis, MN, USA. ORCID
  4. Stacia L Koppenhafer: Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Iowa, Iowa City, IA, USA.
  5. David J Gordon: Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Iowa, Iowa City, IA, USA. ORCID
  6. Peter M Gordon: Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Minnesota, Minneapolis, MN, USA. ORCID

Abstract

No abstract text available.

References

  1. Oncogene. 2015 Jun 4;34(23):2978-90 [PMID: 25132270]
  2. Invest New Drugs. 2016 Feb;34(1):49-60 [PMID: 26612134]
  3. Oncotarget. 2016 Aug 16;7(33):53377-53391 [PMID: 27438145]
  4. Cancer Chemother Pharmacol. 2020 Jan;85(1):9-20 [PMID: 31512029]
  5. Leukemia. 2020 Nov;34(11):2898-2902 [PMID: 32488115]
  6. Comput Struct Biotechnol J. 2015 Sep 25;13:504-13 [PMID: 26949479]
  7. Cancer Discov. 2021 May;11(5):1082-1099 [PMID: 33408242]
  8. Cancer Res. 2010 Jan 15;70(2):440-6 [PMID: 20068163]
  9. Nucleic Acids Res. 2020 Jul 2;48(W1):W488-W493 [PMID: 32246720]
  10. Nature. 2019 May;569(7757):503-508 [PMID: 31068700]
  11. Oncotarget. 2017 Jun 28;8(50):87016-87032 [PMID: 29152060]
  12. Cancer Lett. 2021 Jan 28;497:202-211 [PMID: 32991949]
  13. Curr Hematol Malig Rep. 2017 Jun;12(3):197-206 [PMID: 28353016]
  14. J Hematol Oncol. 2015 Nov 05;8:125 [PMID: 26542114]
  15. Clin Cancer Res. 2019 Apr 1;25(7):2278-2289 [PMID: 30563935]

Grants

  1. R37 CA217910/NCI NIH HHS
  2. R37 CA240846/NCI NIH HHS

MeSH Term

Animals
Cell Line, Tumor
Cell Proliferation
Checkpoint Kinase 1
Deoxycytidine
Drug Synergism
Humans
Mice
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Protein Kinase Inhibitors
Pyrazines
Pyrazoles
Gemcitabine

Chemicals

Protein Kinase Inhibitors
Pyrazines
Pyrazoles
prexasertib
Deoxycytidine
Checkpoint Kinase 1
Gemcitabine

Word Cloud

Created with Highcharts 10.0.0Preclinicalefficacyprexasertibacutelymphoblasticleukemia

Similar Articles

Cited By

No available data.